Latest Intelligence in Belgium

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Volkswagen: bowing out of Belgium?

Reports have suggested that the head of the VW brand is considering closing its Brussels plant. The scaling down of the carmaker's western European plants, followed by relocation in countries with lower labor costs, is vital to VW's future survival. However a local backlash over the Belgian closure could do VW's image further harm at an already difficult time.

Published By Datamonitor
13 Jul 2005
CommentWire
CommentWire

Virco: looking into the future of AIDS therapy

Published By Datamonitor
17 Jul 2001
ResearchWire
ResearchWire

Used cars: French cars will hold their value better than UK's

Published By Datamonitor
26 Nov 2001
CommentWire
CommentWire

UCB: positive outlook for Keppra

UCB has reported significant top-line phase III results for its epilepsy medicine Keppra over placebo in reducing the frequency of partial onset seizures in pediatric patients. While these results demonstrate Keppra's broad potential to reduce the burden of epilepsy across a wider-range of patients, they also point to a positive future for UCB's epilepsy franchise.

Published By Datamonitor
20 Apr 2007
CommentWire
CommentWire

UCB: development of Keppra's successor makes headway

UCB has initiated a Phase III clinical program for brivaracetam as an adjunctive treatment in partial-onset epilepsy. Should it perform well here and gain marketing approval, the launch of this drug would serve to strengthen UCB's epilepsy franchise, as well as potentially representing an important treatment option for patients with refractory epilepsy.

Published By Datamonitor
26 Oct 2007
CommentWire
CommentWire

UCB: continuing the European Mid-Pharma consolidation craze

Having enjoyed past success from acquisitions, Belgian-based UCB is now looking to Schwarz Pharma, with its impressive late-stage pipeline, to boost its growth potential. This merger agreement is the latest in a recent 'acquisition frenzy', and highlights the current trend towards consolidation in the European pharmaceutical sector.

Published By Datamonitor
26 Sep 2006
CommentWire
CommentWire

UCB/Schwarz: a leading CNS proposition moves a step closer

The $5.5 billion takeover of Schwarz Pharma by Belgian rival UCB looks likely to go ahead, as preliminary figures show that UCB has received tenders in excess of 76% of the share capital of Schwarz Pharma. In addition to generating significant synergies, the deal is expected to create a leading neurology-focused pharmaceuticals group.

Published By Datamonitor
12 Dec 2006
CommentWire
CommentWire

Texaco/UPS: drop zones enable eCommerce

Published By Datamonitor
29 Jan 2001
CommentWire
CommentWire

TDG: strengthening its presence - but maybe not enough

Published By Datamonitor
19 Feb 2001
CommentWire
CommentWire

Swissair: flights grounded amid bankruptcy chaos

Published By Datamonitor
02 Oct 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.